coinfection in the ER
Using a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency department
Gallery

Using a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency department

,

Using a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency department

,
2023-02-13T12:02:25-08:00

Ram-Mohan, N. et al. Microbiology Spectrum (asm.org). Oct 2022.

Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis.

We’re seeking teammates with expertise, curiosity and passion for solving clinical challenges with a focus on patient outcomes. If that sounds like you, check out our Careers Page.

Close up of hand holding briefcase and face mask

© Copyright, Inflammatix, Inc.     All Rights Reserved   |   Terms & Conditions   |   Privacy & Cookies Statement
Inflammatix, TriVerity and BacVerity are trademarks of Inflammatix, Inc.

Go to Top